Recent News

• 03.07.2025 - ProPhase Labs to Present at the Investor Summit Virtual on March 11
• 03.07.2025 - ProPhase Labs to Present at the Investor Summit Virtual on March 11
• 02.25.2025 - ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs
• 02.25.2025 - ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs
• 02.25.2025 - ProPhase Labs presentation as of 2.25.2025
• 02.20.2025 - ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables
• 02.20.2025 - ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables
• 02.18.2025 - ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
• 02.18.2025 - ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
• 01.22.2025 - ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm

Recent Filings

• 02.21.2025 - 8-K Current report
• 02.21.2025 - 3 Initial statement of beneficial ownership of securities
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.13.2025 - 8-K Current report
• 01.30.2025 - 8-K Current report
• 01.30.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.23.2025 - 8-K Current report